- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07825012
External Validation of the FedHist Dynamic Early Warning Model for Mortality Risk in Critically Ill Patients: A Prospective Multicenter Study
The purpose of this study is to assess how accurately FedHist, an artificial intelligence model, predicts the risk of death in critically ill patients. Patients in intensive care units (ICUs) can become worse quickly. Updating risk estimates as new clinical information becomes available may help identify patients at higher risk. FedHist uses routinely collected clinical information to estimate a patient's risk of dying in the ICU within the next 24 hours. These estimates are updated every 6 hours.
This study will evaluate FedHist prospectively across several hospitals. The model will be integrated into hospital clinical information systems, and its predictions will be compared with observed patient outcomes. The study aims to determine whether FedHist provides accurate predictions across hospitals with different patient populations and clinical practices.
연구 개요
상세 설명
Critically ill patients can deteriorate rapidly, creating a need for timely and repeated assessment of mortality risk. Conventional severity assessments, including the Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores, provide clinically useful information. However, risk assessments based on data from defined assessment periods may not fully capture evolving clinical trajectories. Models that incorporate longitudinal clinical data may support more frequent assessment of short-term mortality risk.
Artificial intelligence offers opportunities to integrate clinical information collected over time for dynamic risk prediction. However, models developed using data from a single center or database may perform differently in other settings. Differences in patient characteristics, disease severity, measurement frequency, and clinical workflows can affect predictive performance. Privacy requirements, data governance policies, and institutional control over data also limit the pooling of patient records for conventional centralized model development.
FedHist was developed using a federated learning framework incorporating electronic health records from more than 250,000 critically ill patients across five countries and regions. This framework enabled collaborative model development while raw patient data remained at the contributing institutions. FedHist generates an updated estimate of the risk of ICU death within the next 24 hours at 6-hour intervals.
Previous evaluations showed a macro-averaged area under the receiver operating characteristic curve (AUROC) of 0.893 in internal validation. AUROCs were 0.881 in the NWICU external validation cohort and 0.961 in the prospective CDIC cohort. FedHist outperformed the corresponding locally trained models. When only 10% of the development data at each site were used, its performance approached or exceeded that of local models trained on the full development datasets. These findings support further prospective evaluation following integration into routine clinical information systems across multiple hospitals.
This prospective multicenter study will externally validate the previously developed FedHist model in participating ICUs. The model will be integrated into local clinical information systems to generate risk estimates using prospectively collected clinical data. Predictions will be compared with observed ICU outcomes to assess performance in predicting death within the subsequent 24 hours. The study will evaluate predictive performance across participating hospitals and assess the generalizability of FedHist under routine clinical conditions.
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: hui chen
- 전화번호: +86-18006138640
- 이메일: huichen.icu@gmail.com
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Admission to a participating ICU
Exclusion Criteria:
- Age younger than 18 years.
- Expected ICU length of stay shorter than 24 hours.
- Refusal to provide written informed consent.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
ICU mortality
기간: From ICU admission to ICU discharge or 90 days after ICU admission, whichever occurs first.
|
The proportion of patients who die from any cause during the ICU stay, with follow-up capped at 90 days after ICU admission.
For patients whose ICU stay exceeds 90 days, vital status at day 90 will be used to determine the mortality outcome.
|
From ICU admission to ICU discharge or 90 days after ICU admission, whichever occurs first.
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- 2026ZDSYLL335-P01
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .